Consistently, results of xenograft experiments showed that ATRA inhibited tumor growth and increased the sensitivity to cisplatin, which was largely abrogated by the depletion of VHL (Fig. 3I, J and Supplementary Fig. 4H). This evidence concerns the gene VHL and neoplasm.